VZV Infected Cell Extract - New Lot2
| Virus Strain | Ellen |
| Host Cell | Normal Human Dermal Fibroblast (NHDF) |
| Cell Line Characterization | Confirmed Negative for HIV and Hepatitis B |
| Purity | Infected cell extract enriched for viral proteins |
| Inactivation | Verified by tissue culture infectivity assay. |
| Supplied In | 100 mM Glycine pH 9.5 |
| Protein Concentration | 0.50 mg/ml |
| Fill Volume | 1.03 ml (VV037-1) or 25.2 ml (VV037-25) |
| ELISA (IgG) Titer | >1:3,200 |
| Western Blot Titer | 50 µg/cm |
| Reference and/or Additional Reading | J. Med. Virology (1984), 13(4):361 |
ELISA Results
Antigen is Virusys # VV037 VZV Infected Cell Extract coated at various dilutions in PBS. Primary antibodies are human plasmas previously characterized for VZV serology. See SOP-138 for procedure.
Western Blot Results
Antigen is Virusys # VV037 VZV Infected Cell Extract at 50 µg/cm. Primary antibodies are human plasmas previously characterized for VZV serology. See SOP-128 for procedure.
This product is intended for research and manufacturing uses only. It is not a diagnostic device. It is supplied frozen on dry ice - upon receipt, store at -70°C. Product degradation will result from multiple freeze/thaw cycles. It is suggested that the antigen be stored in use size aliquots and thawed just prior to use. Storage at 2 - 8°C for up to twelve hours is acceptable for unused portions.
